MORONI, ELISABETTA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 354
EU - Europa 144
AS - Asia 138
SA - Sud America 3
OC - Oceania 1
Totale 640
Nazione #
US - Stati Uniti d'America 353
SG - Singapore 126
IT - Italia 121
FI - Finlandia 7
DE - Germania 4
HK - Hong Kong 4
NL - Olanda 4
BR - Brasile 2
FR - Francia 2
LV - Lettonia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
BE - Belgio 1
CN - Cina 1
IE - Irlanda 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PA - Panama 1
SE - Svezia 1
UZ - Uzbekistan 1
Totale 640
Città #
Santa Clara 310
Singapore 60
Milan 47
Brescia 11
Alzano Lombardo 10
Helsinki 7
Padova 7
Trieste 7
Ashburn 5
Cirimido 4
Falkenstein 4
Hong Kong 4
Bergamo 3
Scandicci 3
Florence 2
Los Angeles 2
Novara 2
Ponzano Veneto 2
Riga 2
Abu Dhabi 1
Almaty 1
Amsterdam 1
Auckland 1
Baku 1
Bishkek 1
Bologna 1
Brussels 1
Buenos Aires 1
Campinas 1
Colombo 1
Dublin 1
Fort Worth 1
Naples 1
Olivet 1
Paris 1
Phoenix 1
Reston 1
Reykjavik 1
Seattle 1
Springfield 1
Tashkent 1
Valenza 1
Vargem Grande Paulista 1
Vientiane 1
Totale 517
Nome #
Frontiers and Challenges of Computing ncRNAs Biogenesis, Function and Modulation 43
Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1 28
Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1 26
The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein 26
Transcription factor protein interactomes reveal genetic determinants in heart disease 25
Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1 23
How aberrant N-glycosylation can alter protein functionality and ligand binding: An atomistic view 20
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern 20
HIF1alfa-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia 18
Design and Test of Molecules that Interfere with the Recognition Mechanisms between the SARS-CoV-2 Spike Protein and Its Host Cell Receptors 17
Visualizing the Dynamics of a Protein Folding Machinery: The Mechanism of Asymmetric ATP Processing in Hsp90 and its Implications for Client Remodelling 17
Machine Learning Prediction of Allosteric Drug Activity from Molecular Dynamics 16
Target oriented-drug discovery: unraveling the molecular interaction between Leishmania Hsp90 and a celastrol carboxamide derivative 15
Studying the Dynamics of a Complex G-Quadruplex System: Insights into the Comparison of MD and NMR Data 15
Integrating Protein Interaction Surface Prediction with a Fragment-Based Drug Design: Automatic Design of New Leads with Fragments on Energy Surfaces 14
Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives 13
Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II 13
A Fe2+-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes 12
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 12
Design of allosteric stimulators of the HSP90 ATPase as novel anticancer leads 11
Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical Probes 11
Novel PARP-1 Inhibitor scaffolds disclosed by a dynamic structure-based pharmacophore approach 11
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 11
Atomistic Simulations of the Mechanisms of the Poorly Catalytic Mitochondrial Chaperone Trap1: Insights into the Effects of Structural Asymmetry on Reactivity 11
A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein 10
Impact of Mutations on NPAC Structural Dynamics: Mechanistic Insights from MD Simulations 10
Design and synthesis of cyclic peptides targeting Gas6 10
Conformational Behavior of SARS-Cov-2 Spike Protein Variants: Evolutionary Jumps in Sequence Reverberate in Structural Dynamic Differences 10
Allosteric Regulation Points Control the Conformational Dynamics of the Molecular Chaperone Hsp90 10
Chemical and Biophysical Approaches to Allosteric Modulation 10
Dynamic-based discovery of new allosteric ligands targeting the Hsp90 C-terminal inhibitor binding site 9
Synthesis of Functionalized 2-(4-Hydroxyphenyl)-3-methylbenzofuran Allosteric Modulators of Hsp90 Activity 9
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization. 9
Structural determinants of cold activity and glucose tolerance of a family 1 glycoside hydrolase (GH1) from Antarctic Marinomonas sp. ef1 9
N-Glycosylation-Induced Pathologic Protein Conformations as a Tool to Guide the Selection of Biologically Active Small Molecules 8
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors 8
The Dynamics of the Folding Machinery 8
N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease 8
Computational approaches meet experiments to design new allosteric ligands 8
Investigating dynamic and energetic determinants of protein nucleic acid recognition: Analysis of the zinc finger zif268-DNA complexes 8
Cracking the chaperone code through the computational microscope 8
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 8
Using QM/MM Molecular Dynamics to Model Reactivity in the mitochondrial Chaperone Trap1 8
Identification of DNA-binding protein target sequences by physical effective energy functions: Free energy analysis of lambda repressor-DNA complexes 8
Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design 8
Conformational regulation of Hsp90 through mutation and small molecules 8
Structures, dynamics, complexes, and functions: From classic computation to artificial intelligence 8
Insights from molecular dynamics simulations for the development of modulators of mitochondrial Hsp90 (Trap1) activity 7
Molecular dynamics simulations of hsp90 with an eye to inhibitor design. 7
Evaluation of docking procedures reliability in affitins-partners interactions 7
3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues 7
molecular dynamics simulations reveal the mechanisms of allosteric activation of Hsp90 by designed ligands 7
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation 7
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy 7
The Dynamics of Drug Discovery 7
Identification of a new scaffold for Hsp90 C-terminal inhibition 7
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation 7
Investigating Dynamic and Energetic Determinants of Protein Nucleic Acid Recognition: Analysis of the Zinc Finger Zif268-DNA Complexes 6
Expedient Access to 2-Benzazepines by Palladium-Catalyzed C-H Activation: Identification of a Unique Hsp90 Inhibitor Scaffold 6
Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography 6
Second generation of fucose-based DC-SIGN ligands: Affinity improvement and specificity versus Langerin 6
Structure and sequence determinants of aggregation investigated with molecular dynamics 6
Exploiting conformational dynamics in drug discovery: Design of C-terminal inhibitors of Hsp90 with improved activities 6
Activation of Hsp90 activity and conformational dynamics through computationally designed allosteric ligands: functional implications 6
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 6
Conformational regulation of Hsp90 though mutations and small molecules 6
Assessment of Mutational Effects on Peptide Stability through Confinement Simulations 6
Modifying Hsp90 dynamics and functional relationships through rationally designed allosteric activators 6
The Structural Asymmetry of Mitochondrial Hsp90 (Trap1) Determines Fine Tuning of Functional Dynamics 6
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors 6
MM/PBSA analysis of molecular dynamics simulations of bovine beta-lactoglobulin: free energy gradients in conformational transitions? 3
Structure and sequence determinants of aggregation investigated with molecular dynamics 2
Totale 781
Categoria #
all - tutte 2.616
article - articoli 2.267
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.883


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202413 0 0 0 0 0 0 0 0 1 2 0 10
2024/2025768 2 3 70 54 250 201 43 117 28 0 0 0
Totale 781